Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma

M. Eid, P. Karousi, L. Kunovský, Š. Tuček, D. Brančíková, Z. Kala, O. Slabý, J. Mayer, CK. Kontos, J. Trna

. 2021 ; 9 (10) : . [pub] 20211014

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22001548

Grantová podpora
MUNI/A/1595/2020 Ministry of Health, Czech Republic

Pancreatic ductal adenocarcinoma (PDAC) is increasing in incidence and is still associated with a high rate of mortality. Only a minority of patients are diagnosed in the early stage. Radical surgery is the only potential curative procedure. However, radicality is reached in 20% of patients operated on. Despite the multidisciplinary approach in resectable tumors, early tumor recurrences are common. Options on how to select optimal candidates for resection remain limited. Nevertheless, accumulating evidence shows an important role of circulating non-coding plasma and serum microRNAs (miRNAs), which physiologically regulate the function of a target protein. miRNAs also play a crucial role in carcinogenesis. In PDAC patients, the expression levels of certain miRNAs vary and may modulate the function of oncogenes or tumor suppressor genes. As they can be detected in a patient's blood, they have the potential to become promising non-invasive diagnostic and prognostic biomarkers. Moreover, they may also serve as markers of chemoresistance. Thus, miRNAs could be useful for early and accurate diagnosis, prognostic stratification, and individual treatment planning. In this review, we summarize the latest findings on miRNAs in PDAC patients, focusing on their potential use in the early stage of the disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22001548
003      
CZ-PrNML
005      
20220112153634.0
007      
ta
008      
220107s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biomedicines9101468 $2 doi
035    __
$a (PubMed)34680585
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Eid, Michal $u Department of Hematology, Oncology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
245    14
$a The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma / $c M. Eid, P. Karousi, L. Kunovský, Š. Tuček, D. Brančíková, Z. Kala, O. Slabý, J. Mayer, CK. Kontos, J. Trna
520    9_
$a Pancreatic ductal adenocarcinoma (PDAC) is increasing in incidence and is still associated with a high rate of mortality. Only a minority of patients are diagnosed in the early stage. Radical surgery is the only potential curative procedure. However, radicality is reached in 20% of patients operated on. Despite the multidisciplinary approach in resectable tumors, early tumor recurrences are common. Options on how to select optimal candidates for resection remain limited. Nevertheless, accumulating evidence shows an important role of circulating non-coding plasma and serum microRNAs (miRNAs), which physiologically regulate the function of a target protein. miRNAs also play a crucial role in carcinogenesis. In PDAC patients, the expression levels of certain miRNAs vary and may modulate the function of oncogenes or tumor suppressor genes. As they can be detected in a patient's blood, they have the potential to become promising non-invasive diagnostic and prognostic biomarkers. Moreover, they may also serve as markers of chemoresistance. Thus, miRNAs could be useful for early and accurate diagnosis, prognostic stratification, and individual treatment planning. In this review, we summarize the latest findings on miRNAs in PDAC patients, focusing on their potential use in the early stage of the disease.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Karousi, Paraskevi $u Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, 15701 Athens, Greece
700    1_
$a Kunovský, Lumír $u Department of Gastroenterology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic $u Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
700    1_
$a Tuček, Štěpán $u Department of Hematology, Oncology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
700    1_
$a Brančíková, Dagmar $u Department of Hematology, Oncology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
700    1_
$a Kala, Zdeněk $u Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
700    1_
$a Slabý, Ondřej $u Department of Biology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic $u Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic
700    1_
$a Mayer, Jiří $u Department of Hematology, Oncology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
700    1_
$a Kontos, Christos K $u Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, 15701 Athens, Greece
700    1_
$a Trna, Jan $u Department of Gastroenterology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic $u Department of Gastroenterology and Digestive Endoscopy, Masaryk Memorial Cancer Institute Brno, 65653 Brno, Czech Republic
773    0_
$w MED00205373 $t Biomedicines $x 2227-9059 $g Roč. 9, č. 10 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34680585 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20220112153630 $b ABA008
999    __
$a ind $b bmc $g 1745522 $s 1152695
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 9 $c 10 $e 20211014 $i 2227-9059 $m Biomedicines $n Biomedicines $x MED00205373
GRA    __
$a MUNI/A/1595/2020 $p Ministry of Health, Czech Republic
LZP    __
$a Pubmed-20220107

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace